Gensight Biologics will participate to the 11th Annual World Orphan Drug & Cell&Gene Therapy Congress to be held in a virtual format from Monday 2 November to Thursday 5 November 2020.
Magali Taiel, Chief Medical Officer, will be part of a panel discussion.
Panel Discussion – Title: Optimising clinical development strategies for gene therapies
- Date: Tuesday, 3 November, 2020
- Time: 1:35pm – 3:35pm CET
- Session: Cell&Gene Therapy – Clinical Development